Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Nutex Health Inc(NUTX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NUTX
10/02/2026: NUTX (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Nutex Health Inc is a unique healthcare company that combines a network of specialized micro-hospitals with a cloud-based population health management platform. Its primary business strength lies in providing accessible emergency and inpatient care through a smaller, more efficient facility footprint. The company's growth story hinges on scaling its micro-hospital network while expanding the reach of its Clinigence analytics software. However, investors must weigh these opportunities against significant execution risks, competitive pressure from massive hospital chains, and the inherent volatility of the healthcare facilities sector. Nutex is best suited for growth-oriented investors who are comfortable with higher volatility and are closely monitoring the company's ability to improve operational margins.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company operates in a growth-oriented niche, but faces significant scaling challenges. |
| Momentum investor | Weak fit | The stock has historically lacked the consistent upward trend required for pure momentum strategies. |
| Value investor | Mixed fit | Valuation fluctuates, but the company's profitability profile makes a traditional value thesis difficult to apply. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses on reinvesting cash flow. |
| Low-risk investor | Weak fit | High operational leverage and sector-specific regulatory risks contribute to elevated volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is susceptible to significant price swings due to its small-cap nature and sector sensitivity. |
| Valuation risk | Medium / high | Profitability remains inconsistent, making valuation metrics sensitive to operational updates. |
| Competition risk (large hospital systems) | High | Large-scale competitors have deeper resources to defend market share and lower their own costs. |
| Business quality | Medium | The business model is unique, but it remains in a development and scaling phase. |
| Dividend income | Low / none | No income component exists for investors seeking dividends. |
| Execution risk | High | The ability to successfully manage multiple facilities while deploying health software is complex. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 319.08% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.45B USD | Price to earnings Ratio 8.2 | 1Y Target Price 288.2 |
Price to earnings Ratio 8.2 | 1Y Target Price 288.2 | ||
Volume (30-day avg) 160.0K shares | Beta 2.02 | 52 Weeks Range 83.99 - 224.28 | Updated Date 10/02/2026 |
52 Weeks Range 83.99 - 224.28 | Updated Date 10/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 25.88 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Micro-Hospital Services | Inpatient and emergency care revenue generated from patient visits. | This is the primary revenue engine relying on local patient volumes. |
| Population Health Analytics | Subscription and licensing revenue for the Clinigence software platform. | This segment provides tech-enabled, recurring revenue potential. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE 8.2 | Forward PE - | Enterprise Value 852.08M | Price to Sales(TTM) 1.72 |
Enterprise Value 852.08M | Price to Sales(TTM) 1.72 | ||
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA 89.97 | Shares Outstanding 6.85M | Shares Floating 4.15M |
Shares Outstanding 6.85M | Shares Floating 4.15M | ||
Percent Insiders 29.23 | Percent Institutions 44 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Nutex Health Inc
Exchange NASDAQ | Headquarters Houston, TX, United States | ||
IPO Launch date 2022-04-04 | Chairman of the Board & CEO Dr. Thomas T. Vo M.B.A., M.D. | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1037 | Website https://www.nutexhealth.com |
Full time employees 1037 | Website https://www.nutexhealth.com | ||
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.